Gemcitabine and cisplatin (GC) +/- subsequent maintenance therapy with single-agent gemcitabine in advanced non-small cell lung cancer (NSCLC): Preliminary results of a randomized trial of the Central European Cooperative Oncology Group (CECOG)

Maciej Krzakowski,M. Wenczl,Thomas Brodowicz,Valentina Tzekova,Rodryg Ramlau,N. Ghilezan,Branka Čučević,Ernst Ulsperger,C. Zielinski,Matjaz Zwitter

Gemcitabine and cisplatin (GC) +/- subsequent maintenance therapy with single-agent gemcitabine in advanced non-small cell lung cancer (NSCLC): Preliminary results of a randomized trial of the Central European Cooperative Oncology Group (CECOG)

2004

Maciej Krzakowski
M. Wenczl
Thomas Brodowicz
Valentina Tzekova
Rodryg Ramlau
N. Ghilezan
Branka Čučević
Ernst Ulsperger
C. Zielinski
Matjaz Zwitter

7067 Background: The optimal treatment duration for NSCLC patients is still a matter of discussion. Objectives of this trial were to compare time to progressive disease (TTPD) in patients treated w...

Keywords:

non-small cell lung cancer (NSCLC)
Randomized controlled trial
Cisplatin
Gemcitabine
Maintenance therapy
Oncology
Internal medicine
Medicine
single agent

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations